Capital Analysts LLC’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11K | Sell |
338
-339
| -50% | -$11K | ﹤0.01% | 1124 |
|
|
2025
Q1 | $22K | Sell |
677
-3,046
| -82% | -$99K | ﹤0.01% | 970 |
|
|
2024
Q4 | $145K | Sell |
3,723
-577
| -13% | -$22.5K | 0.01% | 541 |
|
|
2024
Q3 | $194K | Sell |
4,300
-40
| -0.9% | -$1.81K | 0.01% | 471 |
|
|
2024
Q2 | $181K | Sell |
4,340
-325
| -7% | -$13.6K | 0.01% | 471 |
|
|
2024
Q1 | $212K | Sell |
4,665
-18
| -0.4% | -$818 | 0.01% | 431 |
|
|
2023
Q4 | $217K | Buy |
4,683
+384
| +9% | +$17.8K | 0.01% | 407 |
|
|
2023
Q3 | $175K | Buy |
4,299
+279
| +7% | +$11.4K | 0.01% | 409 |
|
|
2023
Q2 | $195K | Buy |
4,020
+267
| +7% | +$13K | 0.01% | 382 |
|
|
2023
Q1 | $185K | Sell |
3,753
-532
| -12% | -$26.2K | 0.01% | 390 |
|
|
2022
Q4 | $217K | Buy |
4,285
+1,265
| +42% | +$64.1K | 0.01% | 390 |
|
|
2022
Q3 | $152K | Buy |
3,020
+666
| +28% | +$33.5K | 0.01% | 390 |
|
|
2022
Q2 | $115K | Sell |
2,354
-338
| -13% | -$16.5K | 0.01% | 414 |
|
|
2022
Q1 | $162K | Buy |
+2,692
| New | +$162K | 0.01% | 362 |
|